HIGHLIGHTS
- who: Top from the 126, UnivParis-Sud, CNRS, Institut de Cancérologie Gustave-Roussy, Villejuif, France Laboratory of Molecular Biology, Research Institute for Health Sciences and Technology, University of Mons, Mons, Belgium have published the research work: Cxcr4-Sdf1 axis, in the Journal: (JOURNAL)
- what: The authors propose that controls the cellular migration of mesenchymal stem cells through the receptor.
SUMMARY
The copy number of DUX4 ORF may vary from several units to several hundred making it Oncotarget into chondrocytes, osteocytes, adipocytes and, more controversially, to other cell types (for review . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.